Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals (AMLX)

36.64 -0.36 (0.97%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/29/23)

Latest Headlines

Amylyx Pharmaceuticals Announces Completion of Enrollment in Global Phase 3 PHOENIX Trial of AMX0035 in ALS February 2, 2023 9:00 AM - BizWire Form 5 Amylyx Pharmaceuticals, For: Dec 31 Filed by: Morningside Venture Investments Ltd January 11, 2023 4:08 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Yeramian Patrick D January 10, 2023 7:23 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Cohen Joshua B January 10, 2023 7:21 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: FRATES JAMES M January 10, 2023 7:21 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Olinger Margaret January 10, 2023 7:20 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Klee Justin B. January 10, 2023 7:13 PM - SEC Filing BofA Securities Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy January 5, 2023 6:20 AM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Dec 30 Filed by: FRATES JAMES M January 4, 2023 9:34 PM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Dec 01 December 6, 2022 4:07 PM - SEC Filing Amylyx Pharmaceuticals to Participate in the Evercore ISI 5th Annual HealthCONx Conference November 22, 2022 9:00 AM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $51 at Citi November 11, 2022 3:59 AM - StreetInsider Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q3 EPS by 1c November 10, 2022 5:01 PM - StreetInsider Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 November 10, 2022 4:15 PM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Nov 10 November 10, 2022 4:08 PM - SEC Filing Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results November 10, 2022 4:01 PM - BizWire Full Article List